Akebia Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
01.04.25
/
50%
€1.85
Target price
01.04.26
€5.54
Performance (%)
-37.57%
Price
23.01.26
€1.15
Summary
This prediction is currently active. Massive losses of -37.57% have been the result for the BUY prediction by Jefferies_Financial_. This prediction currently runs until 01.04.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | 3.085% | 3.085% |
| iShares Core DAX® | -1.764% | 2.259% |
| iShares Nasdaq 100 | -1.632% | -0.193% |
| iShares Nikkei 225® | -2.451% | 4.086% |
| iShares S&P 500 | -2.252% | -0.151% |
Comments by Jefferies_Financial_ for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat